Skip to main content
. 2022 Feb 3;11(3):532. doi: 10.3390/cells11030532

Figure 7.

Figure 7

TAT-GILZ treatment rescued 30% of mice from lethal pneumonia. BALB/c mice were infected with S. pneumoniae (1 × 105 CFU, i.n.), treated with TAT (0.1 mg/kg, i.p.) or TAT-GILZ (0.2 mg/kg, i.p.) at 12, 24 and 48 h p.i. (A), the groups were monitored for lethality rates (B) percentage of weight lost at day five (C). Vehicle group received DMSO 0.6%. N = 6–7 animals per group. #### p < 0.0001 when comparing TAT-GILZ-treated pneumococcal pneumonia mice to vehicle or TAT groups, by 1-way ANOVA.